drugset / Trial / NCT00509613
Phase 1 Study With Sorafenib and Sirolimus
NaSingle-groupOpen-label
Summary
The purpose of the trial is to identify the recommended dose of sorafenib and sirolimus for combination therapy in subsequent phase 2 trials.
Timeline
- Start
- 2007-06
- Primary completion
- 2009-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sirolimus | Small molecule | — | — |
| Subject | Sorafenib | Small molecule | — | — |